Filing identity and reporting period
The supplied filing is Schweitzer-Mauduit International, Inc. (SWM), Form 10-K for the fiscal year ended December 31, 2014, filed February 27, 2015. It is not a filing for Mativ Holdings, Inc.; investors should confirm the intended company and period. Annual figures below compare 2014 with 2013 unless noted.
Business context and financial results
SWM made specialty papers and reconstituted tobacco products, alongside a growing Filtration business following its 2013 DelStar acquisition and two additional asset acquisitions in December 2014. Tobacco-related products accounted for about 76% of 2014 net sales. The four largest tobacco customers represented 46% of sales.
- Revenue: $794.3 million, up 2.8% from $772.8 million. Filtration contributed $127.4 million, mostly reflecting a full year of DelStar; Paper revenue fell 8.7% to $496.3 million and Reconstituted Tobacco fell 24.2% to $170.6 million.
- Profit and margins: Gross profit was $218.8 million, down 13.4%; gross margin declined to 27.5% from 32.7%. Operating profit was $106.1 million versus $124.9 million, with operating margin of 13.4% versus 16.2%. Net income rose to $89.7 million from $76.1 million; diluted EPS increased to $2.93 from $2.42. The 2014 effective tax rate was 18.9%, versus 41.5%.
- Fourth quarter: Sales were $181.7 million versus $196.5 million in Q4 2013. Operating profit was $17.3 million versus a $0.7 million loss; net income was $18.5 million versus a $9.7 million loss. Q4 2014 restructuring and impairment expense was $6.5 million, compared with $38.4 million in Q4 2013.
- Cash flow and investment: Cash provided by operations was $165.9 million, down from $178.1 million. Capital spending was $35.1 million; acquisitions used $32.6 million and investment in equity affiliates used $8.8 million. Operating cash flow less capital spending was approximately $130.8 million.
- Liquidity and debt: Cash and equivalents were $290.3 million, including $284.7 million held by foreign subsidiaries. Total debt was $440.1 million, up from $385.4 million; debt-to-capital rose to 47.4% from 40.7%. Availability under the $500 million revolving facility was $74.5 million, with another $30.4 million available under overdraft facilities and lines of credit. SWM reported compliance with its debt covenants.
Material changes and unusual items
- Underlying Paper and Reconstituted Tobacco volumes weakened: Paper volume declined 0.9%, while Reconstituted Tobacco volume declined 28.2%. Lower demand, pricing and product mix, plus reduced factory overhead absorption, pressured gross profit.
- Filtration sales increased substantially with DelStar included for a full year and the December Pronamic and Smith & Nephew asset acquisitions. Filtration reported $10.2 million of operating profit, compared with a $1.1 million loss in the short 2013 ownership period.
- Restructuring and impairment expense fell to $13.1 million from $41.3 million. The prior-year amount included a $37.2 million impairment of the mothballed Philippines RTL facility; its year-end 2014 net book value was $30.8 million.
- 2014 included a $63.0 million foreign-currency translation loss in other comprehensive income. SWM also repurchased $50.0 million of shares under its authorization and paid $44.5 million in dividends.
Outlook, risks and contingencies
Management expected 2015 RTL volumes outside China to increase slightly and total RTL volumes, including CTS in China, to grow more than 20%. It expected CTS to achieve profitable operations in 2015 and ramp toward full capacity by 2016. Planned 2015 capital spending was approximately $30 million to $35 million. SWM anticipated continued cigarette-paper attrition and LIP pricing pressure, while pursuing Filtration and Advanced Fibers & Materials growth, cost reductions and further diversification. These are management expectations, not guarantees.
- Key risks include declining cigarette consumption and tobacco regulation, customer concentration, intense pricing competition, raw-material and energy costs, foreign-exchange exposure, and execution and integration risks in acquisitions and restructuring. Brazil was experiencing drought-related electricity concerns.
- Brazilian tax assessments totaled approximately $38 million for raw-material ICMS matters, of which about $17 million was covered by an indemnification, and approximately $18 million for electricity-related assessments. SWM disputed the assessments and recorded no liability; outcomes were uncertain.
- SWM faced ongoing challenges to several LIP-related European patents and had begun patent-infringement litigation in Germany in January 2015. Patent opposition and litigation outcomes could affect its technology position and involve unpredictable costs.
- The combined projected benefit obligation for U.S. and French pension and other postretirement plans was underfunded by $32.4 million at year-end. The filing also disclosed Brazil’s separate tax and legal risks and a potential for further impairment or restructuring charges.
Important facts for investors to verify
- Confirm that SWM’s 2014 Form 10-K, rather than a Mativ filing, is the intended document.
- Assess whether tobacco-volume and pricing declines are offset by Filtration growth and whether recent acquisitions deliver expected returns.
- Review debt capacity, covenant headroom, cash location and accessibility, and the sustainability of dividends and share repurchases.
- Track CTS ramp-up and profitability, the Philippines facility’s disposition or impairment risk, and the results of restructuring efforts.
- Monitor outcomes of the Brazilian tax assessments and LIP patent proceedings, as well as exposure to currency, pulp, resin and energy costs.
The independent auditor gave an unqualified opinion on the financial statements and internal control over financial reporting. The audit excluded internal controls of the two businesses acquired in December 2014, consistent with the stated first-year SEC guidance.